Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-10-27 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学持股5%以上股东减持股份计划完成暨减持结果公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement from a company disclosing the completion of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the shareholder's identity, shareholding percentages before and after the reduction, the method and period of share reduction, and confirms that the plan has been fully implemented. This type of document is a notification about changes in major shareholding levels, specifically a 'Major Shareholding Notification'. It is not a financial report, earnings release, or management report, but a regulatory announcement about shareholding changes.
2022-10-27 Chinese
南微医学科技股份有限公司关于向参股子公司增资并转让设备暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction involving capital increase and equipment transfer to a subsidiary. It details the transaction terms, pricing, approvals by the board and supervisory committee, and independent directors' opinions. It does not contain financial statements or comprehensive financial data but is a regulatory disclosure about a specific corporate transaction. The document length is under 5,000 characters and is a formal announcement of a corporate action rather than a full report or financial statement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about a related party transaction.
2022-10-27 Chinese
南微医学科技股份有限公司2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年第三季度报告' which translates to '2022 Third Quarter Report'. It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes for the third quarter of 2022. The report is unaudited as indicated. The content includes comprehensive financial figures and analysis for a period shorter than a full fiscal year (the third quarter). This matches the definition of an Interim / Quarterly Report (IR). The document length is over 13,000 characters and contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence. 9M 2022
2022-10-27 Chinese
南微医学科技股份有限公司股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by 南微医学科技股份有限公司. It details the stock price movements over specific dates, confirms no undisclosed material information, and provides risk warnings to investors. It references stock exchange rules and trading regulations but does not contain financial statements or detailed financial data. The document length is short (1605 characters) and it is clearly an announcement about stock price abnormality rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about stock price behavior and compliance with disclosure rules.
2022-10-18 Chinese
南微医学科技股份有限公司持股5%以上股东减持达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a significant shareholder (Huakang Limited) reducing its shareholding by more than 1%. It details the shareholding changes, dates, and percentages before and after the reduction. The document explicitly states it is a "持股5%以上股东减持达到1%的提示性公告" which translates to a "Notification of a shareholder holding more than 5% reducing their shares by 1%". This fits the definition of a Major Shareholding Notification (MRQ). The document is not a full financial report, earnings release, or management report, nor is it an announcement of a meeting or voting results. It is a regulatory disclosure about shareholding changes crossing thresholds. The document length is short and focused on shareholding changes, confirming MRQ classification.
2022-10-09 Chinese
南微医学持股5%以上股东减持股份数量过半及减持达到1%暨公司第一大股东变更的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement regarding the reduction of shareholding by a major shareholder (holding more than 5%) and the resulting change in the company's largest shareholder. It includes specifics about the number of shares reduced, the percentage of total shares, the timeline of the reduction, and the impact on control and governance. The document does not contain financial statements or comprehensive financial data but focuses on shareholding changes and disclosures related to insider share transactions. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is 4131 characters, which is sufficient for a detailed notification but not a full financial report. There is no indication that this is a report publication announcement or a regulatory filing fallback. Therefore, the correct classification is MRQ with high confidence.
2022-09-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.